Associations of Cigarette Smoking With Subclinical Inflammation and Atherosclerosis: ELSA-Brasil (The Brazilian Longitudinal Study of Adult Health)

Journal of the American Heart Association

Volumn 6, Issue 6, 2017, Pages

  Kianoush, Sina ^a   Yakoob, Mohammad Yawar ^a   Al Rifai, Mahmoud ^a,b   Defilippis, Andrew P ^a,c   Bittencourt, Marcio S ^d   Duncan, Bruce B ^e   Bensenor, Isabela M ^d   Bhatnagar, Aruni ^c   Lotufo, Paulo A ^d   Blaha, Michael J ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE WICHITA   (United States)

^c University of Louisville School of Medicine   (United States)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

^e FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Atherosclerosis; Inflammation; Smoking; Subclinical atherosclerosis risk factor; Tobacco products

Indexed keywords

C REACTIVE PROTEIN; AUTACOID; BIOLOGICAL MARKER;

ADULT; AGED; AGING; ANKLE BRACHIAL INDEX; ARTICLE; ATHEROSCLEROSIS; BRAZIL; BRAZILIAN; CAROTID INTIMA-MEDIA THICKNESS; CIGARETTE SMOKING; COHORT ANALYSIS; CORONARY ARTERY CALCIUM SCORE; CROSS-SECTIONAL STUDY; CURRENT SMOKER; EX-SMOKER; FEMALE; HUMAN; INFLAMMATION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NEVER SMOKER; PROSPECTIVE STUDY; SMOKING CESSATION; ARTERIAL WALL THICKNESS; ASYMPTOMATIC DISEASE; BLOOD; CAROTID ARTERY DISEASE; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DIAGNOSTIC IMAGING; MIDDLE AGED; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; ODDS RATIO; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SMOKING; STATISTICAL MODEL; TIME FACTOR;

ADULT; AGED; ANKLE BRACHIAL INDEX; ASYMPTOMATIC DISEASES; ATHEROSCLEROSIS; BIOMARKERS; BRAZIL; C-REACTIVE PROTEIN; CAROTID ARTERY DISEASES; CAROTID INTIMA-MEDIA THICKNESS; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; LINEAR MODELS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; RISK REDUCTION BEHAVIOR; SMOKING; SMOKING CESSATION; TIME FACTORS;

EID: 85030648019     PISSN: None     EISSN: 20479980     Source Type: Journal    
DOI: 10.1161/JAHA.116.005088     Document Type: Article

References (43)

1. GBD 2013 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386:2287–2323.
2. Brugha TS, Murray C. Global, regional and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 195 countries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388:1659–1724.
3. Ribeiro ALP, Duncan BB, Brant LC, Lotufo PA, Mill JG, Barreto SM. Cardiovascular health in Brazil trends and perspectives. Circulation. 2016;133:422–433.
4. Ng M, Freeman MK, Fleming TD, Robinson M, Dwyer-Lindgren L, Thomson B, Wollum A, Sanman E, Wulf S, Lopez AD. Smoking prevalence and cigarette consumption in 187 countries, 1980–2012. JAMA. 2014;311:183–192.
5. Marano KM, Kathman SJ, Jones BA, Nordskog BK, Brown BG, Borgerding MF. Study of cardiovascular disease biomarkers among tobacco consumers. Part 3: evaluation and comparison with the US National Health and Nutrition Examination Survey. Inhal Toxicol. 2015;27:167–173.
6. Golzarand M, Toolabi K, Ebrahimi-Mameghani M, Aliasgarzadeh A, Arefhosseini S. Association between modifiable lifestyle factors and inflammatory markers in patients with metabolic syndrome. East Mediterr Health J. 2012;18:735– 741.
7. Zatu MC, Van Rooyen JM, Schutte AE. Smoking and vascular dysfunction in Africans and Caucasians from South Africa. Cardiovasc J Afr. 2011;22:18–24.
8. Reichert V, Xue X, Bartscherer D, Jacobsen D, Fardellone C, Folan P, Kohn N, Talwar A, Metz CN. A pilot study to examine the effects of smoking cessation on serum markers of inflammation in women at risk for cardiovascular disease. Chest. 2009;136:212–219.
9. Lao XQ, Jiang CQ, Zhang WS, Adab P, Lam TH, Cheng KK, Thomas GN. Smoking, smoking cessation and inflammatory markers in older Chinese men: the Guangzhou Biobank Cohort Study. Atherosclerosis. 2009;203:304–310.
10. Madsen C, Nafstad P, Eikvar L, Schwarze PE, Ronningen KS, Haaheim LL. Association between tobacco smoke exposure and levels of C-reactive protein in the Oslo II Study. Eur J Epidemiol. 2007;22:311–317.
11. Bakhru A, Erlinger TP. Smoking cessation and cardiovascular disease risk factors: results from the Third National Health and Nutrition Examination Survey. PLoS Med. 2005;2:e160.
12. Ohsawa M, Okayama A, Nakamura M, Onoda T, Kato K, Itai K, Yoshida Y, Ogawa A, Kawamura K, Hiramori K. CRP levels are elevated in smokers but unrelated to the number of cigarettes and are decreased by long-term smoking cessation in male smokers. Prev Med. 2005;41:651–656.
13. Bazzano LA, He J, Muntner P, Vupputuri S, Whelton PK. Relationship between cigarette smoking and novel risk factors for cardiovascular disease in the United States. Ann Intern Med. 2003;138:891–897.
14. Bermudez EA, Rifai N, Buring JE, Manson JE, Ridker PM. Relation between markers of systemic vascular inflammation and smoking in women. Am J Cardiol. 2002;89:1117–1119.
15. Hastie CE, Haw S, Pell JP. Impact of smoking cessation and lifetime exposure on C-reactive protein. Nicotine Tob Res. 2008;10:637–642.
16. Lehmann N, Mohlenkamp S, Mahabadi AA, Schmermund A, Roggenbuck U, Seibel R, Gronemeyer D, Budde T, Dragano N, Stang A, Mann K, Moebus S, Erbel R, Jockel KH. Effect of smoking and other traditional risk factors on the onset of coronary artery calcification: results of the Heinz Nixdorf Recall Study. Atherosclerosis. 2014;232:339–345.
17. Jockel KH, Lehmann N, Jaeger BR, Moebus S, Mohlenkamp S, Schmermund A, Dragano N, Stang A, Gronemeyer D, Seibel R, Mann K, Volbracht L, Siegrist J, Erbel R. Smoking cessation and subclinical atherosclerosis–results from the Heinz Nixdorf Recall Study. Atherosclerosis. 2009;203:221–227.
18. Hansen K, Ostling G, Persson M, Nilsson PM, Melander O, Engstrom G, Hedblad B, Rosvall M. The effect of smoking on carotid intima-media thickness progression rate and rate of lumen diameter reduction. Eur J Intern Med. 2016;28:74–79.
19. Baldassarre D, Castelnuovo S, Frigerio B, Amato M, Werba JP, De Jong A, Ravani AL, Tremoli E, Sirtori CR. Effects of timing and extent of smoking, type of cigarettes, and concomitant risk factors on the association between smoking and subclinical atherosclerosis. Stroke. 2009;40:1991–1998.
20. Fan M, Raitakari OT, Kahonen M, Juonala M, Hutri-Kahonen N, Porsti I, Viikari J, Lehtimaki T. The association between cigarette smoking and carotid intima-media thickness is influenced by the-930A/G CYBA gene polymorphism: the Cardiovascular Risk in Young Finns Study. Am J Hypertens. 2009;22:281–287.
21. Hisamatsu T, Miura K, Arima H, Kadota A, Kadowaki S, Torii S, Suzuki S, Miyagawa N, Sato A, Yamazoe M. Smoking, smoking cessation, and measures of subclinical atherosclerosis in multiple vascular beds in Japanese men. JAm Heart Assoc. 2016;5:e003738. DOI: 10.1161/JAHA.116.003738.
22. Bhatnagar A. E-cigarettes and cardiovascular disease risk: evaluation of evidence, policy implications, and recommendations. Curr Cardiovasc Risk Rep. 2016;10:24.
23. McEvoy JW, Nasir K, DeFilippis AP, Lima JA, Bluemke DA, Hundley WG, Barr RG, Budoff MJ, Szklo M, Navas-Acien A, Polak JF, Blumenthal RS, Post WS, Blaha MJ. Relationship of cigarette smoking with inflammation and subclinical vascular disease: the Multi-Ethnic Study of Atherosclerosis. Arterioscler Thromb Vasc Biol. 2015;35:1002–1010.
24. McEvoy JW, Blaha MJ, DeFilippis AP, Lima JA, Bluemke DA, Hundley WG, Min JK, Shaw LJ, Lloyd-Jones DM, Barr RG. Cigarette smoking and cardiovascular events role of inflammation and subclinical atherosclerosis from the Multiethnic Study of Atherosclerosis. Arterioscler Thromb Vasc Biol. 2015;35:700–709.
25. Lotufo PA. Smoking and cancer: Brazil and the Global Burden of Disease initiative. Sao Paulo Med J. 2015;133:385–387.
26. Schmidt MI, Duncan BB, Mill JG, Lotufo PA, Chor D, Barreto SM, Aquino EM, Passos VMA, Matos SM, Maria del Carmen BM. Cohort profile: longitudinal study of adult health (ELSA-Brasil). Int J Epidemiol. 2015;44:68–75.
27. Santos IS, Bittencourt MS, Oliveira IR, Souza AG, Meireles DP, Rundek T, Foppa M, Bezerra DC, Freire CM, Roelke LH, Carrilho S, Bensenor IM, Lotufo PA. Carotid intima-media thickness value distributions in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). Atherosclerosis. 2014;237:227–235.
28. Mill JG, Pinto K, Griep RH, Goulart A, Foppa M, Lotufo PA, Maestri MK, Ribeiro AL, Andreao RV, Dantas EM, Oliveira I, Fuchs SC, Cunha Rde S, Bensenor IM. [Medical assessments and measurements in ELSA-Brasil]. Rev Saude Publica. 2013;47:54–62.
29. Santos IS, Alencar AP, Rundek T, Goulart AC, Barreto SM, Pereira AC, Bensenor IM, Lotufo PA. Low impact of traditional risk factors on carotid intima-media thickness: the ELSA-Brasil cohort. Arterioscler Thromb Vasc Biol. 2015;35:2054–2059.
30. Sacks D, Bakal CW, Beatty PT, Becker GJ, Cardella JF, Raabe RD, Wiener HM, Lewis CA. Position statement on the use of the ankle-brachial index in the evaluation of patients with peripheral vascular disease: a consensus statement developed by the standards division of the society of cardiovascular & interventional radiology. J Vasc Interv Radiol. 2002;13:353.
31. Miname M, Bensenor IM, Lotufo PA. Different methods of calculating anklebrachial index in mid-elderly men and women: the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). Braz J Med Biol Res. 2016;49:e5734.
32. Bensenor IM, Goulart AC, Santos IS, Bittencourt MS, Pereira AC, Santos RD, Nasir K, Blankstein R, Lotufo PA. Association between a healthy cardiovascular risk factor profile and coronary artery calcium score: results from the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). Am Heart J. 2016;174:51–59.
33. Pereira AC, Gomez LM, Bittencourt MS, Staniak HL, Sharovsky R, Foppa M, Blaha MJ, Bensenor IM, Lotufo PA. Age, gender, and race-based coronary artery calcium score percentiles in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). Clin Cardiol. 2016;39:352–359.
34. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol. 1990;15:827–832.
35. Roth PL, Switzer FS, Switzer DM. Missing data in multiple item scales: a Monte Carlo analysis of missing data techniques. Organ Res Methods. 1999;2:211– 232.
36. Pell JP, Haw S, Cobbe S, Newby DE, Pell AC, Fischbacher C, McConnachie A, Pringle S, Murdoch D, Dunn F. Smoke-free legislation and hospitalizations for acute coronary syndrome. N Engl J Med. 2008;359:482–491.
37. Benowitz NL. Emerging nicotine delivery products. Implications for public health. Ann Am Thorac Soc. 2014;11:231–235.
38. Barnett TE, Soule EK, Forrest JR, Porter L, Tomar SL. Adolescent electronic cigarette use: associations with conventional cigarette and hookah smoking. Am J Prev Med. 2015;49:199–206.
39. Nance R, Delaney J, McEvoy JW, Blaha MJ, Burke GL, Navas-Acien A, Kaufman JD, Oelsner EC, McClelland RL. Smoking intensity (pack/day) is a better measure than pack-years or smoking status for modeling cardiovascular disease outcomes. J Clin Epidemiol. 2016;S0895–4356:30483–30488.
40. Libby P, Ridker PM. Inflammation and atherosclerosis: role of C-reactive protein in risk assessment. Am J Med. 2004;116:9–16.
41. Jones MR, Magid HS, Al-Rifai M, McEvoy JW, Kaufman JD, Hinckley Stukovsky KD, Barr G, Szklo M, Polak J, Burke G, Post WS, Blaha MJ, Navas-Acien A. Secondhand smoke exposure and subclinical cardiovascular disease: the Multi-Ethnic Study of Atheroslcerosis. J Am Heart Assoc. 2016;5:e002965. DOI: 10.1161/JAHA.115.002965.
42. Blaha MJ, Budoff MJ, DeFilippis AP, Blankstein R, Rivera JJ, Agatston A, O’Leary DH, Lima J, Blumenthal RS, Nasir K. Associations between C-reactive protein, coronary artery calcium, and cardiovascular events: implications for the JUPITER population from MESA, a population-based cohort study. Lancet. 2011;378:684–692.
43. Keith RJ, Al Rifai M, Carruba C, De Jarnett N, McEvoy JW, Bhatnagar A, Blaha MJ, Defilippis AP. Tobacco use, insulin resistance, and risk of type 2 diabetes: results from the Multi-Ethnic Study of Atherosclerosis. PLoS One. 2016;11: e0157592.